ZILEUTON Side Effects

4736436-9 | Blood Sodium Decreased, Dehydration, Gangrene, Insomnia, Neutropenia, Oral Intake Reduced, Thrombocytopenia
on Jul 19, 2005 Male patient from UNITED STATES , 59 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Zileuton (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, dehydration, gangrene, insomnia, neutropenia, oral intake reduced, thrombocytopenia. Zileuton dosage: 600 Mg Qid Po. During the same period patient was treated with CARBOPLATIN (729 Mg Iv) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (3690 Mg Iv) (View Gemcitabine Review and Gemcitabine Label ), CELECOXIB (10400 Mg Po) (View Celecoxib Review and Celecoxib Label ). Patient was hospitalized.

4736435-7 | Atrial Fibrillation, Cyanosis, Haemodynamic Instability, Loss Of Consciousness, Myocardial Infarction, Myocardial Ischaemia, Pericardial Effusion, Respiratory Distress, Syncope
Patient was taking Zileuton (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cyanosis, haemodynamic instability, loss of consciousness, myocardial infarction, myocardial ischaemia, pericardial effusion, respiratory distress, syncope on Jul 19, 2005 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 150.8 lb, was diagnosed with non-small cell lung cancer and. Zileuton dosage: 600 Mg Qid Po. During the same period patient was treated with CARBOPLATIN (489 Mg Once Iv) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (1710 Mg Once Iv) (View Gemcitabine Review and Gemcitabine Label ).

4717683-9 | Asthenia, Bacteria Urine, Bacterial Infection, Decreased Appetite, Fatigue, Haemolytic Anaemia, Hypotension, International Normalised Ratio Increased, Otitis Externa
Adverse event was reported on Jun 29, 2005 by a Male patient taking Zileuton (View Usage) (Dosage: 2400 Mg Qid Po) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 60 years of age, weighting 154.3 lb, After Zileuton was administered, patient had the following side effects: asthenia, bacteria urine, bacterial infection (What is bacterial infection?), decreased appetite, fatigue, haemolytic anaemia, hypotension, international normalised ratio increased, otitis externa. During the same period patient was treated with GEMCITABINE (1000 Mg/m2 Qwk Iv) (View Gemcitabine Review and Gemcitabine Label ), CARBOPLATIN (375 Mg Once Iv) (View Carboplatin Review and Carboplatin Label ), CELECOXIB (400 Mg Bid Po) (View Celecoxib Review and Celecoxib Label ). Patient was hospitalized.

4717682-7 | Abasia, Blood Creatine Phosphokinase Increased, Myalgia, Myositis, Nausea, Pain In Extremity, Pneumonia, Sinus Tachycardia
on Jun 29, 2005 Male patient from UNITED STATES , 52 years of age, weighting 141.3 lb, was diagnosed with non-small cell lung cancer and was treated with Zileuton (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, blood creatine phosphokinase increased, myalgia, myositis (What is myositis?), nausea (What is nausea?), pain in extremity, pneumonia (What is pneumonia?), sinus tachycardia. Zileuton dosage: 600 Mg Qid Po. During the same period patient was treated with GEMCITABINE (1730 Mg Qwk Iv) (View Gemcitabine Review and Gemcitabine Label ), CARBOPLATIN (677 Mg Once Iv) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.


4717335-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Platelet Count Decreased, White Blood Cell Count Decreased
on Jun 29, 2005 Male patient from UNITED STATES , 54 years of age, weighting 247.6 lb, was diagnosed with non-small cell lung cancer and was treated with Zileuton (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, platelet count decreased, white blood cell count decreased. Zileuton dosage: 600 Mg Qid Po. During the same period patient was treated with CARBOPLATIN (810 Mg Qday Iv) (View Carboplatin Review and Carboplatin Label ), CELECOXIB (400 Mg Bid Po) (View Celecoxib Review and Celecoxib Label ), GEMCITABINE (100 Mg/m2 Qwk Iv) (View Gemcitabine Review and Gemcitabine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DOCUSATE NA (View Docusate Na Review and Docusate Na Label ), MILK OF MAGNESIA (View Milk Of Magnesia Review and Milk Of Magnesia Label ), PROCHLORPERAZINE MALEATE (View Prochlorperazine Maleate Review and Prochlorperazine Maleate Label ).

4717333-1 | Blood Albumin Decreased, Blood Sodium Decreased, Blood Urea Increased, Chills, Dehydration, Diarrhoea, Dizziness, Haematocrit Decreased
Patient was taking Zileuton (View Usage). After Zileuton was administered, patient had the following side effects: blood albumin decreased, blood sodium decreased, blood urea increased, chills, dehydration, diarrhoea, dizziness (What is dizziness?), haematocrit decreased on Jun 29, 2005 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 130.3 lb, was diagnosed with non-small cell lung cancer and. Zileuton dosage: 600 Mg Qid Po. During the same period patient was treated with CARBOPLATIN (352 Mg Once Iv) (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (1630 Mg Qwk Iv) (View Gemcitabine Review and Gemcitabine Label ), ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE (View Albuterol Sulfate And Ipratropium Bromide Review and Albuterol Sulfate And Ipratropium Bromide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FOSINOPRIL NA (View Fosinopril Na Review and Fosinopril Na Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

4717332-X | Anaemia, Blood Urea Increased, Coagulopathy, Deep Vein Thrombosis, Dizziness, Dyspnoea, Epistaxis, Gastritis, Gastrointestinal Haemorrhage
Adverse event was reported on Jun 25, 2005 by a Male patient taking Zileuton (View Usage) (Dosage: 600 Mg Qid Po) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 64 years of age, weighting 280.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, blood urea increased, coagulopathy, deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), dyspnoea, epistaxis, gastritis, gastrointestinal haemorrhage. During the same period patient was treated with GEMCITABINE (1000 Mq/sqm Q3wks Iv) (View Gemcitabine Review and Gemcitabine Label ), CARBOPLATIN (960 Mg Q3wks Iv) (View Carboplatin Review and Carboplatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), AMARYL (View Amaryl Review and Amaryl Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ). Patient was hospitalized.